Pharm Exec Talks Partnerships with Sanofi

In this Pharmaceutical Executive video interview, Jesse Mendelsohn, senior vice president at Model N, talks about the influence of Medicare Part D drug price negotiations on manufacturer go-to-market strategies and decision-making, and the industry’s response to the wider dialogue on pricing transparency.

Using prescription digital therapeutics can lead to better outcomes for patients, making them a win-win for pharma and patients.

Kevin Hagan, president and CEO of the PAN Foundation, spoke to PharmExec about the recent IRA changes that impact Medicare, as well as the Foundation's near-term goals.

Pharm Exec's Associate Editor, Christen Harm chats with Jay Sabbah, Senior Director, Marketing, GSK , at the 2019 18th Annual eyeforpharma Philadelphia Conference, Expo & Awards.

Associate Editor, Christen Harm talks with Peter Barschdorff, Vice President, Commercial Insights, GSK , at the 2019 18th Annual eyeforpharma Philadelphia Conference, Expo & Awards.

Pharm Exec's Editorial Director, Lisa Henderson catches up with Chris Sellin, Head of Operational Excellence & Analytics, Takeda (Formerly Shire), at the 2019 18th Annual eyeforpharma Philadelphia Conference, Expo & Awards.